Key result
High adherence to antihypertensive medication was significantly correlated with improved quality of life domains, amidst an overall non-adherence rate of 56.40%.
Why the study?
Data regarding hypertension in the Democratic Republic of the Congo remain scarce, prompting an evaluation of the effects of antihypertensive medication adherence on quality of life.
Does adherence to antihypertensive medication improve quality of life in hypertensive patients?
Cross-Sectional (n=211)
Yes
Does adherence to antihypertensive medication improve quality of life in hypertensive patients?
In hypertensive patients in the Democratic Republic of the Congo, high adherence to antihypertensive medication is significantly correlated with better health-related quality of life.
Answers are grounded in this paper and cite their sources.
May warrant adherence support in DRC hypertension care; leaves open causality and generalizability.
Introduction Hypertension represents a significant public health issue and stands as one of the most prevalent chronic diseases worldwide, affecting both developed and developing nations. Notably, data regarding hypertension in the Democratic Republic of the Congo (DRC) remains scarce. This study sought to evaluate the effects of adherence to antihypertensive medication on the quality of life among hypertensive patients. Method This study focused on hypertensive patients aged 18 and older in Katwa, Butembo, and Musienene from July 1 to November 1, 2024, involving 211 patients selected by convenience sampling. Inclusion required at least six months of treatment. Health-Related Quality of Life (HRQoL) was measured using the SF-36 scale, and medication adherence was assessed with the MMAS-8. Data were analyzed through descriptive statistics and linear regression to examine the relationship between adherence and quality of life. Results The findings indicated a non-adherence rate of 56.40% among participants. Furthermore, the mean scores across various dimensions of quality of life were observed to be relatively low, particularly in the domain of general health, which registered a score of 36.11%, indicative of poor quality of life. A significant correlation was identified between high levels of adherence to medication and improvement in specific domains of quality of life, including physical function, social function, physical limitation, and mental health. Conclusion Hypertensive patients had low treatment adherence, correlating with poor quality-of-life scores, while high adherence was linked to better quality-of-life improvements.
No takes yet. Share an insight, caveat, or question.
Muyisa et al. (2025) conducted a cross-sectional in Hypertension (n=211). Adherence to antihypertensive medication vs. Low adherence was evaluated on Quality of life (SF-36) and medication adherence (MMAS-8). High adherence to antihypertensive medication was significantly correlated with improved quality of life domains, amidst an overall non-adherence rate of 56.40%.
Synapse has enriched 10 related papers. Consider them for comparative context: